On the Way to Becoming a Global Leader in the Point-of-Care Diagnostic Device Field

NanoEnTek has key technology of nano scale Bio-MEMS that organizationally combined microelectromechanical system (MEMS) and biotechnology, which is called technology of the 21st century. Based on the technology, it is expanding its business to life science experiment equipment, medical in-vitro diagnostic device and related solution development. There are about 100 patents of nano convergence technology that were applied and registered.

Especially, one of the company’s key platforms is lab-on-achip, and it is a next generation technology that will contribute to medicine and life science areas.

NanoEnTek recently released the world’s fi rst compact automatic cell analyzer named Countess. In 2009, it sold patent exclusive license of gene delivery system, MicroPorator, to a global company at US$13 million. It will advance its global targets through the world’s fi rst benchtop residual white blood cell counter ADAM-rWBC, pointof- care diagnostic devices FREND PSA Plus, and FREND TSH FDA 510(k) cleared in the United States.

Through active investment, NanoEnTek is now expanding its in-vitro diagnostic business with its existing life science business. In January 2016, it merged with Bio Focus which is a point of care diagnostic devices company based on rapid kit. Together, they have reinforced biology capability and presented customized products for each country because of diversifi cation in platform.

Representative Products for POCT (Pointof- Care-Testing)

The FREND system is a small, rapid and near-patient in-vitro diagnostic for quantitative measurement of biomarkers in patient samples. This quantitative immunoassay analyzer is fast, delivering results within three minutes after a simple three-step process.

And it is easy to use with touch screen GUI, which allows saving in USB drive. It is accurate by performing bett er than other diagnostic devices. It is also compact with 3kg of weight, requiring no restriction for installation space.

What’s more, it is FDA 510K certifi ed.

BioTracer is a rapid diagnostic test that is quick and easy to perform for qualitative measurement. It is capable of manufacturing gold-conjugates, recombinant antigen and antibodies. It markets products that satisfy WHO standards (Malaria, HIV), US FDA(hCG) and the CE mark. With accumulated know-how on manufacturing rapid test, its sales extend to over 40 countries.

BUDDI is an image analyzer that evaluates the line signal intensities of analyte and control line on the test device. It has smart connectivity (EMR/LIS & Wi-Fi) with easy and fast test procedures. It also has a user-friendly touchscreen interface.

• NanoEnTek
5, Digital-ro 26 gil, Guro-gu, Seoul, Korea
Tel:(82-2)6220-7861 Fax:(82-2)6220-7999
E-mail: yoona@nanoentek.com Website: http://www.nanoentek.com

korean-electronics.com | Blog Magazine of korean electronics, brands and Goods